EGFR and cholestasis: Conversely, other studies suggest an opposite EGFR function in cholestasis liver injury, demonstrating that the deletion of the catalytic domain of EGFR can be beneficial, reducing collagen gene expression, promoting anti-inflammatory responses, and increasing M2 macrophages that suppress fibrosis.